Entrada Therapeutics Inc (TRDA)
18.70
+0.65
(+3.60%)
USD |
NASDAQ |
Nov 22, 11:41
Entrada Therapeutics Total Assets (Quarterly): 554.59M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 554.59M |
| June 30, 2024 | 581.96M |
| March 31, 2024 | 510.84M |
| December 31, 2023 | 469.19M |
| September 30, 2023 | 485.03M |
| June 30, 2023 | 493.98M |
| March 31, 2023 | 475.57M |
| December 31, 2022 | 252.06M |
| Date | Value |
|---|---|
| September 30, 2022 | 274.46M |
| June 30, 2022 | 295.92M |
| March 31, 2022 | 316.70M |
| December 31, 2021 | 305.83M |
| September 30, 2021 | 132.40M |
| June 30, 2021 | 143.51M |
| December 31, 2020 | 43.53M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
43.53M
Minimum
Dec 2020
581.96M
Maximum
Jun 2024
355.71M
Average
316.70M
Median
Mar 2022
Total Assets (Quarterly) Benchmarks
| Catalyst Pharmaceuticals Inc | 772.01M |
| Vertex Pharmaceuticals Inc | 22.24B |
| Assembly Biosciences Inc | 100.26M |
| Sarepta Therapeutics Inc | 3.600B |
| Regenxbio Inc | 519.11M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 132.14M |
| Shareholders Equity (Quarterly) | 422.45M |
| Current Ratio | 6.591 |